Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06216808 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06216808 · ClinicalTrials.gov record · last posted 2026-08-10

A First-in-human Study of HyperQureTM", Laparoscopic Renal Denervation Therapy in Patient With Resistant Hypertension

Name: A First-in-human Study of HyperQureTM", Laparoscopic Renal Denervation Therapy in Patient With Resistant Hypertension — clinical trial record (NCT06216808)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhaseNot applicable

SponsorDeepQure Inc.

Started2023-12-04

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

HQ-HTN-K01-02 is a prospective, multicenter, single arm, open label, first-in-human study to evaluate the safety and initial efficacy of HyperQureTM, laparoscopic denervation therapy, in patients with resistant hypertension on 3 or more antihypertensive medications

Protocol amendment history 1 change detected by DataLookout

2026-08-11

Enrollment closed, study ongoing

Trial Details

NCT Number	NCT06216808
Lead Sponsor	DeepQure Inc.
Conditions	Resistant Hypertension
Enrollment	10 participants
Start Date	2023-12-04
Primary Completion	2026-02-27 (estimated)
Study Completion	2026-12-27 (estimated)
Updated on ClinicalTrials.gov	2026-08-10